IDH1 and glioblastoma: The most prevalent mutation in GBM, IDH1 R132H, showed a higher mutation frequency in our samples (10.0%, 95% CI: 2.4–17.6) compared to its frequency in TCGA (5.9%, 95% CI: 3.6–8.2) (Table 1, S3 and S4 Tables).